Ueda Ryo 植田良

… Alternative Names

UEDA Ryo 植田良

植田良ウエダリヨウ

Less

Researcher Number	30317143
Other IDs
Affiliation (Current)	2025: 慶應義塾大学, 医学部(信濃町), 准教授
Affiliation (based on the past Project Information) *help	2020 – 2024: 慶應義塾大学, 医学部(信濃町), 講師 2016 – 2019: 慶應義塾大学, 医学部(信濃町), 共同研究員 2011 – 2015: 慶應義塾大学, 医学部, 共同研究員 2012: 慶應義塾大学, 医学部, 研究員 2009 – 2010: 慶應義塾大学, 医学部, 助教 … More 2009: 医学部, 助教 2006: 慶應大, 医学部, 助手 2005: 慶應義塾大学, 医学部, 助手 Less
Review Section/Research Field	Principal Investigator Basic Section 56010:Neurosurgery-related / Cerebral neurosurgery / Neurosurgery Except Principal Investigator Cerebral neurosurgery / Basic Section 56010:Neurosurgery-related / Biological Sciences
Keywords	Principal Investigator 免疫療法 / 脳腫瘍血管新生 / 腫瘍抗原ペプチドワクチン / バイオマーカー / 難治性脳腫瘍 / ペプチドワクチン / 脳腫瘍新生血管 / 脳腫瘍 / 悪性神経膠腫 / 悪性脳腫瘍 … More / 治療効果判定 / 抗腫瘍免疫応答抑制性因子 / 脳腫瘍血管新生性関連因子 / がんワクチン免疫療法 / 腫瘍血管新生 / 抗腫瘍免疫 / がんペプチドワクチン / エクソソーム / 免疫抑制 / がん / microRNA / 脳腫瘍学 / トランスレーショナルリサーチ / 遺伝子 / 免疫学 / 癌 / 脳神経疾患 … More Except Principal Investigator グリオーマ / 脳腫瘍幹細胞 / 免疫抑制 / 免疫療法 / 遺伝子治療 / suicide gene / RRV / NSC / 遊走 / Malignant glioma / 複製型レトロウイルス / iPS細胞 / 透明化 / 自殺遺伝子 / 神経幹細胞 / 悪性神経膠腫 / Genome editing / Suicide gene / Viral vector / Neural stem cell / iPS / Glioma / 微小環境 / 腫瘍幹細胞 / 幹細胞 / クローニング / 未分化 / 増殖因子 / DNAチップ / 免疫回避 / HLA遺伝子導入マウス / RNA干渉 / 網羅的遺伝子解析 / 転移 / 制御性T細胞 / 樹状細胞 / 免疫抵抗性 / 悪性黒色腫 / 上皮間葉転換 / がん幹細胞 / 腫瘍抗原 Less

難治性脳腫瘍血管を標的としたペプチドワクチン療法の新規治療効果予測因子の検証Principal Investigator
- Principal Investigator
  
  植田良
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  Keio University
iPS cells producing retroviral replicating vector for malignant glioma
- Principal Investigator
  
  toda masahiro
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  Keio University
Biomarkers for evaluation of clinical activity of VEGFR-targeted vaccines against malignant brain tumor patientsPrincipal Investigator
- Principal Investigator
  
  Ueda Ryo
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  Keio University
Biomarkers for evaluation of clinical activity of VEGFR-targeted vaccines against malignant brain tumor patientsPrincipal Investigator
- Principal Investigator
  
  UEDA Ryo
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  Keio University
Biomarkers for evaluation of clinical activity of VEGFR-targeted vaccines against malignant glioma patientsPrincipal Investigator
- Principal Investigator
  
  UEDA RYO
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Neurosurgery
- Research Institution
  Keio University
Immune-biomarkers for evaluation of clinical activity of VEGFR-targeted vaccines against malignant glioma patientsPrincipal Investigator
- Principal Investigator
  
  UEDA RYO
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Cerebral neurosurgery
- Research Institution
  Keio University
Immunotherapy targeting brain tumor stem cell antigen and niche
- Principal Investigator
  
  TODA Masahiro
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Cerebral neurosurgery
- Research Institution
  Keio University
Analysis of stemness regulators in brain cancer stem cells
- Principal Investigator
  
  TODA Masahiro
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Cerebral neurosurgery
- Research Institution
  Keio University
MicroRNA-222 is a potential target for developing blood-based diagnostic methods and treatment of malignant gliomaPrincipal Investigator
- Principal Investigator
  
  UEDA Ryo
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Cerebral neurosurgery
- Research Institution
  Keio University
Development of immunotherapy based on the identification of tumor antigens
- Principal Investigator
  
  KAWAKAMI Yutaka
- Project Period (FY)
  2005 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Keio University
CD4及びCD8陽性T細胞に認識されるグリオーマ抗原を用いた特異的免疫療法の確立Principal Investigator
- Principal Investigator
  
  植田良
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Cerebral neurosurgery
- Research Institution
  Keio University

All 2019 2018 2016 2015 2014 2012 2011 2010 2009 2008 2007 2006 Other

All Journal Article Presentation Book Patent

[Book] 実験医学2011
- Author(s)
  植田良
- Total Pages
  131
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-22791355
[Book] 癌細胞由来エクソソームによる免疫系への作用とその臨床応用2011
- Author(s)
  植田良、Li Qian、中村公子、谷口智憲、宮崎潤一郎、川村直、河上裕
- Total Pages
  5
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-22791355
[Book] Innate and adaptive immune regulation and Cancer immunotherapy(Wang RF ed)2010
- Author(s)
  Ueda R, Kawakami Y
- Publisher
  Springer Science/Business Media(in press)
- Data Source
  KAKENHI-PROJECT-17016070
[Book] Wang RF ed, Springer Science/Business Media, New York USA2010
- Author(s)
  Ueda R, Kawakami Y.
- Publisher
  Human tumor antigens recognized by T cells and their implications for cancer immunotherapy in "Innate and adaptive immuneregulation and Cancer immunotherapy"(in press)
- Data Source
  KAKENHI-PROJECT-17016070
[Book] Gene Therapy(Development of individualized immunotherapy based on the analysis on anti-tumor immune responses to the human tumor antigens identified using immunological and genetic methods)2009
- Author(s)
  Kawakami Y, Fujita T, Kudo C, Sakurai T, Udagawa M, Hasegawa G, Ishida A, Kitagawa Y, Tanabe M, Saito M, Izumi Y, Kawamura M, Yaguchi T, Ueda Y, Hayashi E, Wang Q, Tsukamoto N, Matsuzaki Y, Sumimoto H,Takeuchi H, Tanikawa A, Handa M, Amagai M, Kobayashi K, Ikeda Y, Azuma I, Kitajima M
- Data Source
  KAKENHI-PROJECT-17016070
[Journal Article] A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.2019
- Author(s)
  Tamura Ryota, Fujioka Masato, Morimoto Yukina, Ohara Kentaro, Kosugi Kenzo, Oishi Yumiko, Sato Mizuto, Ueda Ryo, Fujiwara Hirokazu, Noji Shinobu, Oishi Naoki, Ogawa Kaoru, Kawakami Yutaka, Ohira Takayuki, Yoshida Kazunari, Toda Masahiro.
- Journal Title
  
  Nature Communications
  
  Volume: 10 Issue: 1 Pages: 5758-5768
- DOI
  10.1038/s41467-019-13640-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K08951, KAKENHI-PROJECT-17H04306
[Journal Article] A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma2019
- Author(s)
  Kikuchi Ryogo、Ueda Ryo、Saito Katsuya、Shibao Shunsuke、Nagashima Hideaki、Tamura Ryota、Morimoto Yukina、Sasaki Hikaru、Noji Shinobu、Kawakami Yutaka、Yoshida Kazunari、Toda Masahiro
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 8 Issue: 2 Pages: 263-263
- DOI
  10.3390/jcm8020263
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08951, KAKENHI-PROJECT-18K19622, KAKENHI-PROJECT-26221005, KAKENHI-PROJECT-17K16661, KAKENHI-PROJECT-17H04306
[Journal Article] A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma2018
- Author(s)
  Shunsuke Shibao, Ryo Ueda, Katsuya Saito, Ryogo Kikuchi, Hideaki Nagashima, Atsuhiro Kojima, Hiroshi Kagami, Eriel Sandika Pareira, Hikaru Sasaki, Shinobu Noji, Yutaka Kawakami, Kazunari Yoshida, and Masahiro Toda
- Journal Title
  
  Oncotarget
  
  Volume: 印刷中
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K10344
[Journal Article] Immunotherapy targeting cancer stem cells2012
- Author(s)
  Kawakami Y, Matsushita M, Ueda R, Tsukamoto N, Ohta S.
- Journal Title
  
  Nihon Rinsho
  
  Volume: 70 (12) Pages: 2142-2146
- NAID
  40019493388
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592172
[Journal Article] Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy.2010
- Author(s)
  Ueda R, et al.
- Journal Title
  
  Int J Cancer. 126(4)
  
  Pages: 919-929
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016070
[Journal Article] Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy.2010
- Author(s)
  Ueda R, Ohkusu-Tsukada K, Fusaki N, Soeda A, Kawase T, Kawakami Y, Toda M
- Journal Title
  
  Int J Cancer 126(4)
  
  Pages: 919-929
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016070
[Journal Article] Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX62008
- Author(s)
  Ueda R, et.al.
- Journal Title
  
  Int J Cancer 112
  
  Pages: 2274-2279
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016070
[Journal Article] Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.2007
- Author(s)
  Ueda R, Kawakami Y, et al.
- Journal Title
  
  Int J Cancer. 120・8
  
  Pages: 1704-1711
- Data Source
  KAKENHI-PROJECT-17016070
[Patent] 癌ワクチン2011
- Inventor(s)
  戸田正博、植田良、塚田晃三
- Industrial Property Rights Holder
  学校法人慶應義塾
- Acquisition Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-22390283
[Patent] 癌ワクチン2011
- Inventor(s)
  戸田正博、植田良
- Industrial Property Rights Holder
  学校法人慶應義塾
- Acquisition Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-22390283
[Patent] 癌ワクチン2006
- Inventor(s)
  戸田正博, 植田良, 塚田晃三
- Industrial Property Rights Holder
  学校法人慶應義塾, 株式会社GBS研究所
- Filing Date
  2006-01-09
- Data Source
  KAKENHI-PROJECT-17790983
[Presentation] 巨大下垂体腺腫に対する治療方針の検討2016
- Author(s)
  菊地亮吾、戸田正博、冨田俊樹、小澤宏之、秋山武和、植田　良、小川　郁
- Organizer
  第26回日本間脳下垂体腫瘍学会
- Place of Presentation
  ザ・セレクトン福島（福島県福島市）
- Year and Date
  2016-02-19
- Data Source
  KAKENHI-PROJECT-15K10344
[Presentation] 再発悪性神経膠腫に対するカクテルペプチドワクチン療法第1/2相臨床試験2016
- Author(s)
  菊地亮吾、戸田正博、田村亮太、長島秀明、柴尾俊輔、齋藤克也、植田良、佐々木光、吉田一成
- Organizer
  第34回日本脳腫瘍学会学術集会
- Place of Presentation
  甲府富士屋ホテル
- Year and Date
  2016-12-05
- Data Source
  KAKENHI-PROJECT-15K10344
[Presentation] 悪性神経膠腫に対するペプチドワクチン療法の臨床試験および新規標的抗原DEPDC1の解析2015
- Author(s)
  菊地亮吾、戸田正博、長島秀明、柴尾俊介、齋藤克也、植田　良、サンペトラ　オルテア、佐谷秀行、佐々木光、吉田一成
- Organizer
  第33回日本脳腫瘍学会学術集会
- Place of Presentation
  グランドプリンスホテル京都 (京都府京都市）
- Year and Date
  2015-12-07
- Data Source
  KAKENHI-PROJECT-15K10344
[Presentation] 悪性神経膠腫に対するVEGFR1/2ワクチン療法2014
- Author(s)
  柴尾俊輔、戸田正博、菊地亮吾、斉藤克也、植田　良、佐々木光、吉田一成
- Organizer
  第32回日本脳腫瘍学会学術集会
- Place of Presentation
  シェラトン・グランデ・トーキョーベイ・ホテル（千葉県）
- Year and Date
  2014-12-01
- Data Source
  KAKENHI-PROJECT-24659657
[Presentation] 悪性神経膠腫に対するVEGFR1/2ワクチン療法2014
- Author(s)
  柴尾俊輔、戸田正博、菊地亮吾、斉藤克也、植田　良、佐々木光、吉田一成
- Organizer
  第32回日本脳腫瘍学会学術集会
- Place of Presentation
  シェラトン・グランデ・トーキョーベイ・ホテル（千葉県浦安市）
- Year and Date
  2014-12-01
- Data Source
  KAKENHI-PROJECT-24592172
[Presentation] 進行・再発悪性グリオーマに対するVEGFRワクチンの第1/2相臨床試験2012
- Author(s)
  戸田正博、斉藤克也、植田良、佐々木光、吉田一成
- Organizer
  第30回日本脳腫瘍学会学術集会
- Place of Presentation
  グランドホテル広島(広島)
- Year and Date
  2012-11-25
- Data Source
  KAKENHI-PROJECT-22390283
[Presentation] 再発膠芽腫に対するVEGFR1/2ペプチドワクチンの臨床試験2012
- Author(s)
  斉藤克也、植田良、佐々木光、戸田正博、吉田一成
- Organizer
  第23回東京脳腫瘍治療懇話会
- Place of Presentation
  センチュリーアイアット東京(東京)
- Year and Date
  2012-01-13
- Data Source
  KAKENHI-PROJECT-22390283
[Presentation] MicroRNA-222 is a potential target for developing blood-based diagnostic methods and treatment of malignant glioma2010
- Author(s)
  植田良、萬倩、谷口智憲、岡田秀穂、小坂展慶、落谷孝広、河上裕
- Organizer
  日本遺伝子治療学会学術総会
- Place of Presentation
  宇都宮
- Year and Date
  2010-07-20
- Data Source
  KAKENHI-PROJECT-22791355
[Presentation] ヒトグリオーマ抗原SOX6とそのT細胞エピトープペプチドの同定2010
- Author(s)
  植田良、戸田正博、副田明男、河瀬斌、河上裕、吉田一成
- Organizer
  第69回日本脳神経外科学会
- Place of Presentation
  福岡コンベンションセンター(福岡)
- Year and Date
  2010-10-29
- Data Source
  KAKENHI-PROJECT-22390283
[Presentation] ヒトグリオーマ抗原SOX6とそのT細胞エピトープペプチドの同定2010
- Author(s)
  植田良、戸田正博、副田明男、河瀬斌、河上裕、吉田一成
- Organizer
  日本脳神経外科学会第69回学術総会
- Place of Presentation
  福岡
- Year and Date
  2010-10-29
- Data Source
  KAKENHI-PROJECT-22390283
[Presentation] MicroRNA-222 is a potential target for developing blood-based diagnostic methods and treatment of malignant glioma2010
- Author(s)
  植田良、萬倩、谷口智憲、岡田秀穂、小坂展慶、落谷孝広、河上裕
- Organizer
  日本癌学会学術総会
- Place of Presentation
  大阪
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-22791355
[Presentation] グリオーマに発現するMicroRNA-222は新規診断法と治療法開発に有用である2010
- Author(s)
  植田良、〓倩、谷口智憲、岡田秀穂、小坂展慶、落谷孝広、河上裕
- Organizer
  日本脳腫瘍学会
- Place of Presentation
  軽井沢
- Year and Date
  2010-11-28
- Data Source
  KAKENHI-PROJECT-22791355
[Presentation] グリオーマに発現するMicroRNA-222は新規診断法と治療法開発に有用である2010
- Author(s)
  植田良、萬倩、谷口智憲、岡田秀穂、小坂展慶、落谷孝広、河上裕
- Organizer
  日本脳腫瘍学会学術総会
- Place of Presentation
  軽井沢
- Year and Date
  2010-11-28
- Data Source
  KAKENHI-PROJECT-22791355
[Presentation] MicroRNA-222 is a potential target for developing blood-based biomarker assay and treatment of malignant glioma2010
- Author(s)
  植田良、〓倩、谷口智憲、岡田秀穂、小坂展慶、落谷孝広、河上裕
- Organizer
  日本遺伝子治療学会
- Place of Presentation
  宇都宮
- Year and Date
  2010-07-02
- Data Source
  KAKENHI-PROJECT-22791355
[Presentation] MicroRNA-222 is a potential target for developing blood-based diagnostic methods and treatment of malignant glioma2010
- Author(s)
  植田良、〓倩、谷口智憲、岡田秀穂、小坂展慶、落谷孝広、河上裕
- Organizer
  日本癌学会
- Place of Presentation
  大阪
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-22791355
[Presentation] 進行及び再発悪性神経膠腫に対するVEGFR1/2ワクチン療法
- Author(s)
  柴尾俊輔、戸田正博、斉藤克也、植田　良、吉田一成
- Organizer
  第31回日本脳腫瘍学会学術集会
- Place of Presentation
  フェニックス・シーガイア・リゾート(宮崎県）
- Data Source
  KAKENHI-PROJECT-24659657
[Presentation] 進行・再発悪性グリオーマに対するVEGFRワクチンの第１/2相臨床試験
- Author(s)
  戸田　正博、斉藤克也、植田　良、佐々木光、吉田一成
- Organizer
  第30回日本脳腫瘍学会学術集会
- Place of Presentation
  グランドプリンスホテル広島　（広島）
- Data Source
  KAKENHI-PROJECT-24659657

1. TODA Masahiro (20217508)

# of Collaborated Projects: 5 results

# of Collaborated Products: 12 results
2. KAWAKAMI Yutaka (50161287)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
3. FUJITA Tomonobu (20199334)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. SAKURAI Toshiharu (20101933)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
5. KUDO Chie (90424126)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. TSUKAMOTO Nobuo (20407117)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. MATSUZAKI Yuriko (40255435)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. TSUKAMOTO Makoto (50365441)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
9. 住本秀敏 (00306838)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. 鈴木ゆり子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ueda Ryo 植田 良

UEDA Ryo 植田 良

植田 良 ウエダ リヨウ

Research Projects

Research Products

Co-Researchers

難治性脳腫瘍血管を標的としたペプチドワクチン療法の新規治療効果予測因子の検証Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

iPS cells producing retroviral replicating vector for malignant glioma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Biomarkers for evaluation of clinical activity of VEGFR-targeted vaccines against malignant brain tumor patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Biomarkers for evaluation of clinical activity of VEGFR-targeted vaccines against malignant brain tumor patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Biomarkers for evaluation of clinical activity of VEGFR-targeted vaccines against malignant glioma patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Immune-biomarkers for evaluation of clinical activity of VEGFR-targeted vaccines against malignant glioma patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Immunotherapy targeting brain tumor stem cell antigen and niche

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of stemness regulators in brain cancer stem cells

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

MicroRNA-222 is a potential target for developing blood-based diagnostic methods and treatment of malignant gliomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of immunotherapy based on the identification of tumor antigens

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

CD4及びCD8陽性T細胞に認識されるグリオーマ抗原を用いた特異的免疫療法の確立Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 実験医学2011

Author(s)

Total Pages

Publisher

Data Source

[Book] 癌細胞由来エクソソームによる免疫系への作用とその臨床応用2011

Author(s)

Total Pages

Ueda Ryo 植田良

UEDA Ryo 植田良

植田良ウエダリヨウ